Prisma Imaging

Must love horses! Save lives while investing in innovative tech

Claim My Business
Security Type
Preferred Stock
Min Investment
Expected Close Date
September 29, 2022
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

Prisma is developing and intends to bring to market a novel system that is capable of providing both digital radiographic and CT imaging of the entire anatomy of a conscious, weight-bearing horse. This development represents an opportunity to improve upon existing imaging employed in the equine industry and will displace traditional CT imaging. These improvements represent the ability to provide better diagnostics, performance, care, and promote the health and welfare of horses compared to current imaging options.


StartEngine OWNERS Exclusive Click here to learn more

$300+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$5,000+ Investment
$5000+ Receive 5% Bonus Shares

$10,000+ Investment
$10,000+ Receive 10% Bonus Shares

$15,000+ Investment
$15,000+ Receive 15% Bonus Shares

$20,000+ Investment
$20,000+ Receive 20% Bonus Shares + Zoom call or in-person meeting with the founder

Management Team / Advisory Board Bios

David Scalzo

Board of Directors Member

David Scalzo is the Founder and Managing Partner for Kirenaga Partners.
David co-founded the fintech company AdvisorEngine, served as its first CFO and sat on the Board of Directors until its sale to FranklinTempleton. In addition, he has extensive experience initiating, growing and managing businesses through various roles at Credit Suisse, Citadel, Bear Stearns, and Precision Plating Company.
David serves on the Board for the Northwestern University Wildcat Athletic Venture Enterprise (NU/WAVE) investment fund, as well as numerous former and current portfolio companies.
David graduated with a BS in Mechanical Engineering from Northwestern University, a Masters in Manufacturing Engineering from the Illinois Institute of Technology, a Masters in Engineering Management from Northwestern University, and a Masters in Business Administration from the Kellogg School of Management at Northwestern University.

Dr. Joseph Heanue

Board of Directors member

Dr. Joe Heanue has significant leadership experience in device and instrumentation research & development within interdisciplinary environments. He previously served as Vice President of Engineering at NexRay and at Signature Bioscience. At NexRay, Joe led the development of a low-dose x-ray imaging system for interventional cardiology. At Signature, he headed a group that delivered prototype RF and microwave spectroscopy instruments to a major instrument partner; the first of these instruments was launched in 2005 by MDS Sciex.  
Joe’s extensive research and development experience includes the analysis and design of complex systems, x-ray and gamma-ray detector development, low-noise analog electronics, data-acquisition systems, signal and image processing, high-speed data-processing architectures, and thin-films failure analysis.  
Joe holds patents for detector and image processing, spectroscopy, and a patent for medical system imaging architecture that is licensed to a major medical equipment manufacturer. He received a BS in Physics from the Massachusetts Institute of Technology and earned his Ph.D. in Electrical Engineering and Computer Science from the University of California at Berkeley. Joe was a postdoctoral researcher at Xerox PARC, and he has completed the Stanford University Executive Program for Growing Companies. 

Dr. Sheetal Patel

Board of Directors member

Dr. Sheetal Patel began her career as a board certified Radiologist, earning her medical degree from University of Miami School of Medicine and going on to complete a residency in Radiology with University of South Florida in Tampa. She furthered her training with a fellowship in Musculoskeletal Radiology, a subspecialty which focuses on sports and orthopedic imaging (including bone and soft tissue tumors). After completing her residency and fellowship she worked with one of the top Radiology groups in Tampa, FL for 9 years.
In 2014, while still practicing radiology, Dr. Patel completed her MBA at University of South Florida, finishing at the top of her class. Soon after earning her MBA she became more actively involved in various business endeavors. Gradually over the course of the next 2-3 years, she transitioned fully into a business role and away from practicing medicine, leading to her current role as COO of the Patel Family Office.
As COO of the Patel Family Office she coordinates operations and investment management across all portfolios. In addition, she actively manages the family’s real estate portfolio consisting of just under $1B in assets across the hospitality, commercial real estate, and development sectors.
Additionally, Dr. Patel is involved with various non-profit and charitable endeavors in the medical and education arenas both within and outside of the Patel Family Foundation which has projects both in the US and abroad. Locally, she also supports the Tampa Bay area as Vice President and board member of The Charity Polo Classic, an organization whose mission is “making a difference by collaborating with local charities to build a better Tampa Bay”. 

Dr. Tobias Funk

Technical Advisor

Dr.Tobias Funk has years of experience in the development of instrumentation for science and medicine. Tobias is an experimental solid-state physicist by training and has focused on utilization of ionizing radiation throughout his career. He developed synchrotron instrumentation for spectroscopy on proteins and ultra-low temperature equipment for nuclear solid-state physics. He has authored over 20 peer-reviewed publications and has over 10 granted and pending patents. 

Hailey Gryka

Technical Advisor

Hailey’s area of expertise lies at the interface of bioinstrumentation and data science. Her experience is in a broad range of bioinstrumentation including magnetic resonance imaging development, point of care device design and testing, neutron generator and linear accelerators for use in healthcare, and development of data processing and machine learning technologies. She has been involved in various stages of the product development pipeline, from design verification to manufacturing quality control. 

Christopher Ellenor, PhD

Technical Advisor

Dr.Christopher Ellenor has experience building experimental systems comprising diverse technical elements. He has great experience on working on laser cooling, imaging and optical design, magnetic trapping of atoms, coil design and ultra-high vacuum (UHV) systems, MRI systems, with a focus on RF safety, as well as embedded and wireless electronics for sensing of patient motion and RF current. 

Russell Ford, Fellow

Technical Advisor

Russell Ford has over 18 years experience in the design and development of innovative medical products and manufacturing processes. Russell’s expertise includes wearable and implantable devices, surgical equipment and complex drug delivery devices. Russell’s has a long history of senior level positions at Zosano Pharma, Abbott Medical Optics, Boston Scientific Neurovascular, and Cygnus Therapeutics. His expertise focuses on applications that include transdermal drug delivery, continuous glucose monitoring, minimally-invasive devices for cataract and laser surgery, as well as neuro-endovascular applications. Russell project management expertise ranges from early stage development through V&V, DFM, high volume scale-up, and commercial launch. Experience also includes development of system level, design, characterization, test method development, materials selection, supplier development, manufacturing process design, and quality systems. 

Chris Mitchell, PhD

Technical Advisor

Dr. Chris Mitchell has more than 25 years of hands-on and leadership experience in the design, development, and characterization of innovative x ray-based imaging systems for medical and industrial applications. Before joining Triple Ring Technologies, Dr. Mitchell served in a variety of positions at Alara, Inc., including VP of R&D and Chief Scientific Officer. While there, he led the development of a patented, award-winning bone densitometer, and several computed radiography-based imaging systems for medical, industrial, and veterinary applications. Prior to Alara, Dr. Mitchell served as Manager, Imaging Technologies, at ARACOR, where he led the development of a number of innovative imaging systems, including high-performance digital radiography, and cone-beam computed tomography for high resolution bone imaging and reverse engineering applications. Chris received his B.A. in applied mathematics from Weber State University, and MS (bioengineering) and Ph.D. (electrical engineering) from the University of Utah. He holds 3 patents in the fields of bone densitometry and computed radiography and has authored or co-authored numerous presentations and journal articles. He is a member of the American Association of Physicists in Medicine (AAPM).
Amount Raised : $34,873
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Preferred securities are a type of investment that generally offers some sort of preferred treatment through a dividend or preferred treatment in a liquidation.

Research Reports

No reports have been submitted

Become a Reporter